BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25591627)

  • 21. Decision making and cancer.
    Reyna VF; Nelson WL; Han PK; Pignone MP
    Am Psychol; 2015; 70(2):105-18. PubMed ID: 25730718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.
    Graber N; Canova N; Bryant-Lukosius D; Robert G; Navarro-Rodrigo B; Trueb L; Coukos G; Eicher M; Corbière T; Colomer-Lahiguera S
    Health Expect; 2024 Aug; 27(4):e14068. PubMed ID: 38937953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient participation: current knowledge and applicability to patient safety.
    Longtin Y; Sax H; Leape LL; Sheridan SE; Donaldson L; Pittet D
    Mayo Clin Proc; 2010 Jan; 85(1):53-62. PubMed ID: 20042562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating lesion-to-lesion heterogeneity into early oncology decision making.
    Kumar R; Qi T; Cao Y; Topp B
    Front Immunol; 2023; 14():1173546. PubMed ID: 37350966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating clinical trial data into daily cancer care.
    Pelusi J
    J Adv Pract Oncol; 2012 Nov; 3(6):378-84. PubMed ID: 25031968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment.
    Zaric B; Perin B; Ilic A; Kopitovic I; Matijasevic J; Andrijevic L; Secen N; Stanic J; Bijelovic M; Kosjerina Z; Antonic M
    Multidiscip Respir Med; 2011 Feb; 6(1):20-7. PubMed ID: 22958587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engaging Our Communities in Active Participation in Clinical Trials: It's a Matter of Trust.
    Maron JL
    Clin Ther; 2024 May; 46(5):381. PubMed ID: 38796337
    [No Abstract]   [Full Text] [Related]  

  • 28. Bringing a humanistic approach to cancer clinical trials.
    Arai RJ; Longo ES; Sponton MH; Del Pilar Estevez Diz M
    Ecancermedicalscience; 2017; 11():738. PubMed ID: 28596804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women's Wellness Program.
    Anderson DJ; Seib C; McCarthy AL; Yates P; Porter-Steele J; McGuire A; Young L
    Menopause; 2015 Sep; 22(9):937-45. PubMed ID: 25608273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.
    Basaria S; Travison TG; Alford D; Knapp PE; Teeter K; Cahalan C; Eder R; Lakshman K; Bachman E; Mensing G; Martel MO; Le D; Stroh H; Bhasin S; Wasan AD; Edwards RR
    Pain; 2015 Feb; 156(2):280-288. PubMed ID: 25599449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming Barriers to Clinical Trial Enrollment.
    Nipp RD; Hong K; Paskett ED
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():105-114. PubMed ID: 31099636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
    Unger JM; Cook E; Tai E; Bleyer A
    Am Soc Clin Oncol Educ Book; 2016; 35():185-98. PubMed ID: 27249699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of Barriers to Minorities' Participation in Cancer Clinical Trials: Implications for Future Cancer Research.
    Salman A; Nguyen C; Lee YH; Cooksey-James T
    J Immigr Minor Health; 2016 Apr; 18(2):447-53. PubMed ID: 25822567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.
    Nielsen ZE; Berthelsen CB
    J Clin Nurs; 2019 Jul; 28(13-14):2443-2461. PubMed ID: 30673153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving Oncology Clinical Trial Participation and Experience.
    Zaharoff B; Cipra S
    Trends Cancer; 2018 Dec; 4(12):793-796. PubMed ID: 30470299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy.
    Asiedu GB; Ridgeway JL; Carroll K; Jatoi A; Radecki Breitkopf C
    Health Expect; 2018 Dec; 21(6):981-989. PubMed ID: 29655265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciding to Enrol in a Cancer Trial: A Systematic Review of Qualitative Studies.
    Viljoen B; Chambers SK; Dunn J; Ralph N; March S
    J Multidiscip Healthc; 2020; 13():1257-1281. PubMed ID: 33149597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients.
    Wenzel JA; Mbah O; Xu J; Moscou-Jackson G; Saleem H; Sakyi K; Ford JG
    J Racial Ethn Health Disparities; 2015 Jun; 2(2):192-9. PubMed ID: 25960945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital health interventions for all? Examining inclusivity across all stages of the digital health intervention research process.
    Krukowski RA; Ross KM; Western MJ; Cooper R; Busse H; Forbes C; Kuntsche E; Allmeta A; Silva AM; John-Akinola YO; König LM
    Trials; 2024 Jan; 25(1):98. PubMed ID: 38291539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.